Aetna, a CVS Health company (NYSE:CVS), announced on Tuesday that it is introducing a generative AI-powered conversational experience in its digital channels designed to simplify healthcare.
This offering will allow members to quickly and easily navigate their benefits for a personalised experience.
The new capability was initially launched to a limited population in October, with access expanding throughout the rest of 2025 and the first half of 2026.
Aetna members will be able to use their device to verbally interact with the assistant with full voice enablement. The assistant will also be embedded within Aetna's recently announced Care Paths feature, a digital experience to help members navigate certain conditions.
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
BD launches IVDR-certified self-collection solution to expand global access to HPV testing
Oticon launches Oticon Zeal, a discreet, fully featured in-the-ear hearing aid
Samsung to invest USD110m in GRAIL and commercialise cancer detection test Galleri in Asia
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux